KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Sales (2016 - 2025)

Resmed (RMD) has disclosed Return on Sales for 17 consecutive years, with 0.28% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 1.0% year-over-year to 0.28%, compared with a TTM value of 0.28% through Dec 2025, up 2.0%, and an annual FY2025 reading of 0.27%, up 5.0% over the prior year.
  • Return on Sales was 0.28% for Q4 2025 at Resmed, up from 0.26% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.28% in Q1 2021 and bottomed at 0.18% in Q4 2023.
  • Average Return on Sales over 5 years is 0.24%, with a median of 0.23% recorded in 2021.
  • The sharpest move saw Return on Sales dropped -8bps in 2022, then increased 9bps in 2024.
  • Year by year, Return on Sales stood at 0.23% in 2021, then fell by -3bps to 0.22% in 2022, then fell by -17bps to 0.18% in 2023, then soared by 50bps to 0.27% in 2024, then increased by 3bps to 0.28% in 2025.
  • Business Quant data shows Return on Sales for RMD at 0.28% in Q4 2025, 0.26% in Q3 2025, and 0.28% in Q2 2025.